Generics: Acquisition specialists- TEVA

Teva, the world's biggest generic drug maker has blanket coverage in its presence especially in USA and Canada. The company with acquisitions before 2005 had managed to place itself in the European market of Italy. After the takeover of Barr in 2008 only which brought Teva, the European assets of Pliva (which Pliva took over form Merck), it has been the sole objective of this generic drug giant to strengthen its position in the largest European generics market of Germany.

Nothing could have been better than Ratiopharm takeover for Teva. With Global Majors like Pfizer and generic drug giant, Actavis in the fray for the Ratiopharm, the stakes for this acquisition were definitely higher.

Ratiopharm businesses were facing problems after the suicide of Adolf Merckle. They were up for sale since the last 9-10 months and were on the lookout for a suitable buyer.

All indicators were pointing at the largest market for generic drugs in Europe- i.e. Germany but also India…………

And that requires no guesswork…..

This blog is co-posted with the Veeda Clinical Research blog.